Immune cell therapy for hepatocellular carcinoma
Abstract Given the success of immune checkpoint inhibitors and chimeric antigen receptor (CAR) T cells in clinical settings, the host immune system plays an important role in the recognition and targeting of tumor cells in cancer immunotherapy. As a result, there have been numerous advancements in i...
Shranjeno v:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2019-05-01
|
| Serija: | Journal of Hematology & Oncology |
| Teme: | |
| Online dostop: | http://link.springer.com/article/10.1186/s13045-019-0742-5 |
| Oznake: |
Brez oznak, prvi označite!
|